Allianz Asset Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
RC
BC
BFA
FMA
BIT
SFM
CCM
Allianz Asset Management's ANGO Position: Q2 2015 in Review
Allianz Asset Management sold out of AngioDynamics (ANGO) in Q2 2015, closing a stake of 46,028 shares — an estimated $819K sold.
Allianz Asset Management first reported a position in ANGO in Q4 2014 and held it in 2 quarters. The position peaked at $1.01M in Q4 2014. 116 funds tracked by Wall St. Rank hold ANGO as of Q2 2015.
- Allianz Asset Management reported no remaining AngioDynamics position as of Q2 2015 after selling out during the quarter.
- Allianz Asset Management sold 46,028 AngioDynamics shares in Q2 2015, an estimated $819K.
- Allianz Asset Management first reported a position in AngioDynamics in Q4 2014 and held it in 2 quarters.
- Allianz Asset Management's AngioDynamics position peaked at $1.01M in Q4 2014.
- 116 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2015.
Based on Allianz Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.